1. Assessment of a novel bidirectional femoral arterial cannula for temporary peripheral circulatory support.
- Author
-
Pellegrino V., Tutungi E., Marasco S., Moshinsky R., Pellegrino V., Tutungi E., Marasco S., and Moshinsky R.
- Abstract
Introduction/Aim: Short-term peripheral mechanical support of the circulation employing common femoral arterial cannulation is used in cardiac surgery and extra-corporeal membrane oxygenation (ECMO). Femoral arterial cannulation however is associated with a significant risk of lower limb ischaemia. In this study we have compared limb perfusion after percutaneous insertion of a novel bidirectional femoral cannula (figure 1) and a standard femoral cannula for temporary circulatory support. Method(s): Veno-arterial ECMO was employed in 6 greyhound dogs. The femoral arteries were cannulated with a novel bidirectional cannula on one side and a standard cannula on the other side using a percutaneous seldinger technique. Ease of insertion, time to insertion, superficial femoral artery blood flow and bleeding were assessed with increasing circuit flow and hip flexion. Result(s): The ease of insertion and time to insertion was similar in both groups. Flow in the superficial femoral artery was significantly greater in the bidirectional cannula group than the standard cannula group. Bleeding at the insertion site did not occur in either group during ECMO support with a range of circuit flows and hip flexion. Conclusion(s): In this study, we have demonstrated the successful insertion and ease of insertion of a novel bidirectional cannula. Superior flow was observed in the superficial femoral artery with the novel bidirectional cannula compared to a standard cannula. A commercial version of this novel bidirectional femoral cannula (Sorin Group USA, a wholly-owned subsidiary of LivaNova PLC, Arvada, Colorado, USA) is currently being evaluated in a phase 1 clinical trial at the Alfred Hospital in Melbourne, Australia.
- Published
- 2017